These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Erythroid stem cell regeneration in normal and plethoric mice treated by cytosinarabinoside.
    Author: Seidel HJ, Kreja L.
    Journal: Exp Hematol; 1980 May; 8(5):541-8. PubMed ID: 7461056.
    Abstract:
    Cytosinarabinoside (6 x 40 mg/kg in 4 h intervals) was used to study hemopoietic regeneration in normal and in hypertransfused mice. About 70-80% of pluripotent stem cells (CFUs), more than 80% of granuloid committed precursors (CFUc) and more than 95% of erythroid committed precursors (CFUE) were eliminated after treatment, and also more than 99% of the erythroblasts in the bone marrow smears. There was no regular difference between normal and hypertransfused groups. Regeneration started at day 2, with control levels of CFUs at day 3 and then overshooting, control levels of CFUc at days 4-5 and a single increase of CFUE at day 3. This rise in CFUE, with values well above control levels, was also present in hypertransfused mice, although less pronounced. In hypertransfused mice the CFUE peak was not allowed by an increase in erythroblast numbers in the femora or 6 h 59Fe uptake into femora or spleen-in contrast to non-plethoric controls. The results indicate the partial Ep independence of regenerating CFUE, as found after treatment with hydroxyurea.
    [Abstract] [Full Text] [Related] [New Search]